IRIS
VILLANI, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.752
NA - Nord America 3.621
AS - Asia 2.582
SA - Sud America 455
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 10.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.533
SG - Singapore 1.045
IE - Irlanda 914
IT - Italia 647
CN - Cina 645
RU - Federazione Russa 588
SE - Svezia 450
UA - Ucraina 369
BR - Brasile 367
HK - Hong Kong 296
FR - Francia 238
VN - Vietnam 193
DE - Germania 187
FI - Finlandia 100
IN - India 98
BD - Bangladesh 84
GB - Regno Unito 84
AT - Austria 44
TR - Turchia 41
AR - Argentina 34
MX - Messico 30
CA - Canada 29
PL - Polonia 27
ID - Indonesia 23
NL - Olanda 21
BE - Belgio 19
IQ - Iraq 18
JP - Giappone 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 15
VE - Venezuela 15
PK - Pakistan 14
TH - Thailandia 13
AE - Emirati Arabi Uniti 11
CO - Colombia 11
SA - Arabia Saudita 11
PH - Filippine 10
RO - Romania 10
UZ - Uzbekistan 10
EG - Egitto 9
CL - Cile 8
EC - Ecuador 8
KE - Kenya 7
LT - Lituania 7
CR - Costa Rica 6
ES - Italia 6
IL - Israele 6
MA - Marocco 6
PY - Paraguay 6
EU - Europa 5
HU - Ungheria 5
JM - Giamaica 5
JO - Giordania 5
LB - Libano 5
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KR - Corea 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
KZ - Kazakistan 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GN - Guinea 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 10.462
Salva come PNG Salva come JPEG
Città #
Dublin 912
San Jose 797
Singapore 509
Nyköping 308
Hong Kong 294
Ashburn 277
Chandler 251
Dallas 222
Jacksonville 218
Beijing 181
Santa Clara 150
Lauterbourg 116
Wilmington 113
Dearborn 104
New York 89
Princeton 89
Moscow 75
The Dalles 75
Helsinki 73
Ho Chi Minh City 57
Nanjing 57
Munich 52
Ann Arbor 51
Foggia 48
Bari 46
Hanoi 43
Rome 41
Los Angeles 34
São Paulo 32
Council Bluffs 27
Vienna 24
Milan 23
Nanchang 23
Des Moines 22
Nuremberg 20
Brussels 19
Shenyang 19
Frankfurt am Main 18
Kraków 18
London 18
San Mateo 18
Brooklyn 17
Kunming 17
Orem 15
Buffalo 14
Gravina in Puglia 14
Haiphong 14
Hebei 14
Naples 14
Tokyo 14
Boardman 13
Gravina In Puglia 13
Jakarta 13
Mexico City 13
Norwalk 13
San Severo 13
Stevenage 13
Bangkok 12
Falkenstein 12
Seattle 12
Shanghai 12
Tianjin 12
Caserta 11
Delhi 11
Hangzhou 11
Houston 11
Woodbridge 11
Chicago 10
Düsseldorf 10
Hillsboro 10
Jiaxing 10
Stockholm 10
Turku 10
Zhengzhou 10
Atlanta 9
Baghdad 9
Belo Horizonte 9
Brno 9
Chennai 9
Manfredonia 9
Orange 9
San Francisco 9
Tashkent 9
Toronto 9
Assago 8
Biên Hòa 8
Boston 8
Cagliari 8
Changsha 8
Guangzhou 8
Warsaw 8
Falls Church 7
Johannesburg 7
Montreal 7
Rio de Janeiro 7
Venice 7
Wuhan 7
Ariano Irpino 6
Barletta 6
Bologna 6
Totale 6.178
Salva come PNG Salva come JPEG
Nome #
Direct-acting antivirals (daas) increase the serum vegf level in patients with chronic hepatitis c: a rationale for tumor recurrence 300
Strategie per la gestione del paziente HBV+ in terapia con immunosoppressori 201
Ulcere da decubito, prevenzione e trattamento. 197
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 181
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 162
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 152
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 151
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 150
To be or not to be: A two years surveillance for a CA 19-9 persistent elevation before cancer diagnosis and bone metastases 146
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 142
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 138
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 130
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 129
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 129
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 126
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 125
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 122
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 118
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 118
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 116
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 115
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 110
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C 109
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 108
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 107
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 106
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 106
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 105
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 105
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 105
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 104
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 104
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 103
HOW OFTEN HAVE WE SAID: IF I HAD THOUGHT OF IT BEFORE? 100
Age, mitochondria and bladder cancer 100
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 100
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 100
Asymptomatic saccular portal vein aneurysm: a case report and review of the literature 100
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases 99
Treatment of chronic HCV infection in the era of protease inhibitors 99
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 99
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 96
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 96
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 96
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 95
Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy 95
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 94
Low Diagnostic Accuracy of Transthoracic Ultrasound for the Assessment of Spontaneous Pneumothorax in the Emergency Setting: A Multicentric Study 93
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 93
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry 92
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 92
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 90
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 89
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 87
A Review on Biological Effects of Ultrasounds: Key Messages for Clinicians 86
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 86
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 86
Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis 84
Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy 84
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 84
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 84
Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis 84
Unmet clinical questions in elderly patients with locally advanced and metastatic bladder cancer 83
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 80
Oxysterols and redox signaling in the pathogenesis of non alcoholic fatty liver disease. 79
Convergence of disciplines: a systematic review of multidisciplinary development approaches in artificial intelligence 78
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 77
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 77
Assessing the impact of COVID-19 on liver cancer management (CERO-19) 77
Direct-acting antivirals for HCV treatment in older patients: A systematic review and meta-analysis 76
In-hospital mortality and length of stay in cirrhotic patients with sepsis treated with non-selective beta-blockers 75
Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary 74
Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry 74
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 74
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry 73
Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 73
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 73
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 72
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 71
Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 71
Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C 71
The GLP-1 receptor agonist Exendin-4 modulates hippocampal NMDA-receptor signalling in aged rats and improves cognitive impairment in diabetic elderly patients 69
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 69
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 69
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 68
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry 68
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 67
Lipid metabolism in development and progression of hepatocellular carcinoma 67
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease 66
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health 66
Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells 64
US-GUIDED PROBE POSITIONING DOES NOT IMPROVE APPLICABILITY BUT REDUCES VARIABILITY IN LIVER STIFFNESS (FIBROSCAN) MEASUREMENT 63
THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 63
Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time 61
Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis 61
Exploring the Relationship between Epicardial Fat Thickness and Coronary Revascularization: Implications for Cardiovascular Health 61
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 61
null 60
INSULINEMIC RESPONSE CURVE AFTER ORAL GLUCOSE TOLERANCE TEST IDENTIFIES EARLY ALTERATIONS OF GLUCOSE METABOLISM IN PATIENTS AFFECTED BY CHRONIC LIVER DISEASE 58
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 58
Totale 9.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022550 28 10 17 10 45 35 38 40 86 93 27 121
2022/20231.979 209 85 89 51 85 159 28 152 1.017 17 49 38
2023/2024425 55 46 16 20 28 90 17 29 7 4 9 104
2024/20251.851 121 14 52 62 75 215 223 117 450 127 223 172
2025/20264.324 231 301 462 461 310 253 846 479 319 331 167 164
Totale 11.053